Proton Pump Inhibitors and Likelihood of Colorectal Cancer in the Korean Population: Insights from a Nested Case–Control Study Using National Health Insurance Data

The potential connection between proton pump inhibitors (PPIs) and colorectal cancer (CRC) risk remains unclear, with specific ethnic genetic backgrounds playing a role in PPI-induced adverse effects. In this nested case–control study, we investigated the risk of CRC in relation to preceding PPI use...

Full description

Bibliographic Details
Main Authors: Mi Jung Kwon, Kyeong Min Han, Joo-Hee Kim, Ji Hee Kim, Min-Jeong Kim, Nan Young Kim, Hyo Geun Choi, Ho Suk Kang
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/23/5606
_version_ 1797400394431725568
author Mi Jung Kwon
Kyeong Min Han
Joo-Hee Kim
Ji Hee Kim
Min-Jeong Kim
Nan Young Kim
Hyo Geun Choi
Ho Suk Kang
author_facet Mi Jung Kwon
Kyeong Min Han
Joo-Hee Kim
Ji Hee Kim
Min-Jeong Kim
Nan Young Kim
Hyo Geun Choi
Ho Suk Kang
author_sort Mi Jung Kwon
collection DOAJ
description The potential connection between proton pump inhibitors (PPIs) and colorectal cancer (CRC) risk remains unclear, with specific ethnic genetic backgrounds playing a role in PPI-induced adverse effects. In this nested case–control study, we investigated the risk of CRC in relation to preceding PPI use and the duration of use using data from the Korean National Health Insurance Service–National Sample Cohort database, including 9374 incident CRC patients and 37,496 controls. To assess the impact of preceding PPI exposure (past vs. current) and use duration (days: <30, 30–90, and ≥90) on incident CRC, we conducted propensity score overlap-weighted multivariate logistic regression analyses, adjusted for confounding factors. Our findings revealed that past and current PPI users had an increased likelihood of developing CRC. Regardless of duration, individuals who used PPIs also had higher odds of developing CRC. Subgroup analyses revealed that CRC occurrence increased independent of history or duration of prior PPI use, consistent across various factors such as age, sex, income level, and residential area. These findings suggest that PPI use, regardless of past or present use and duration of use, may be related to an increased risk of developing CRC in the Korean population.
first_indexed 2024-03-09T01:54:01Z
format Article
id doaj.art-9708c67e2cc04ab2bc4a94f6fe19de56
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T01:54:01Z
publishDate 2023-11-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-9708c67e2cc04ab2bc4a94f6fe19de562023-12-08T15:12:41ZengMDPI AGCancers2072-66942023-11-011523560610.3390/cancers15235606Proton Pump Inhibitors and Likelihood of Colorectal Cancer in the Korean Population: Insights from a Nested Case–Control Study Using National Health Insurance DataMi Jung Kwon0Kyeong Min Han1Joo-Hee Kim2Ji Hee Kim3Min-Jeong Kim4Nan Young Kim5Hyo Geun Choi6Ho Suk Kang7Department of Pathology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14068, Republic of KoreaHallym Data Science Laboratory, Hallym University College of Medicine, Anyang 14068, Republic of KoreaDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14068, Republic of KoreaDepartment of Neurosurgery, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14068, Republic of KoreaDepartment of Radiology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14068, Republic of KoreaHallym Institute of Translational Genomics and Bioinformatics, Hallym University Medical Center, Anyang 14068, Republic of KoreaSuseo Seoul E.N.T. Clinic and MD Analytics, Seoul 06349, Republic of KoreaDepartment of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14068, Republic of KoreaThe potential connection between proton pump inhibitors (PPIs) and colorectal cancer (CRC) risk remains unclear, with specific ethnic genetic backgrounds playing a role in PPI-induced adverse effects. In this nested case–control study, we investigated the risk of CRC in relation to preceding PPI use and the duration of use using data from the Korean National Health Insurance Service–National Sample Cohort database, including 9374 incident CRC patients and 37,496 controls. To assess the impact of preceding PPI exposure (past vs. current) and use duration (days: <30, 30–90, and ≥90) on incident CRC, we conducted propensity score overlap-weighted multivariate logistic regression analyses, adjusted for confounding factors. Our findings revealed that past and current PPI users had an increased likelihood of developing CRC. Regardless of duration, individuals who used PPIs also had higher odds of developing CRC. Subgroup analyses revealed that CRC occurrence increased independent of history or duration of prior PPI use, consistent across various factors such as age, sex, income level, and residential area. These findings suggest that PPI use, regardless of past or present use and duration of use, may be related to an increased risk of developing CRC in the Korean population.https://www.mdpi.com/2072-6694/15/23/5606colorectal cancerproton pump inhibitornational healthcare datanested case–control study
spellingShingle Mi Jung Kwon
Kyeong Min Han
Joo-Hee Kim
Ji Hee Kim
Min-Jeong Kim
Nan Young Kim
Hyo Geun Choi
Ho Suk Kang
Proton Pump Inhibitors and Likelihood of Colorectal Cancer in the Korean Population: Insights from a Nested Case–Control Study Using National Health Insurance Data
Cancers
colorectal cancer
proton pump inhibitor
national healthcare data
nested case–control study
title Proton Pump Inhibitors and Likelihood of Colorectal Cancer in the Korean Population: Insights from a Nested Case–Control Study Using National Health Insurance Data
title_full Proton Pump Inhibitors and Likelihood of Colorectal Cancer in the Korean Population: Insights from a Nested Case–Control Study Using National Health Insurance Data
title_fullStr Proton Pump Inhibitors and Likelihood of Colorectal Cancer in the Korean Population: Insights from a Nested Case–Control Study Using National Health Insurance Data
title_full_unstemmed Proton Pump Inhibitors and Likelihood of Colorectal Cancer in the Korean Population: Insights from a Nested Case–Control Study Using National Health Insurance Data
title_short Proton Pump Inhibitors and Likelihood of Colorectal Cancer in the Korean Population: Insights from a Nested Case–Control Study Using National Health Insurance Data
title_sort proton pump inhibitors and likelihood of colorectal cancer in the korean population insights from a nested case control study using national health insurance data
topic colorectal cancer
proton pump inhibitor
national healthcare data
nested case–control study
url https://www.mdpi.com/2072-6694/15/23/5606
work_keys_str_mv AT mijungkwon protonpumpinhibitorsandlikelihoodofcolorectalcancerinthekoreanpopulationinsightsfromanestedcasecontrolstudyusingnationalhealthinsurancedata
AT kyeongminhan protonpumpinhibitorsandlikelihoodofcolorectalcancerinthekoreanpopulationinsightsfromanestedcasecontrolstudyusingnationalhealthinsurancedata
AT jooheekim protonpumpinhibitorsandlikelihoodofcolorectalcancerinthekoreanpopulationinsightsfromanestedcasecontrolstudyusingnationalhealthinsurancedata
AT jiheekim protonpumpinhibitorsandlikelihoodofcolorectalcancerinthekoreanpopulationinsightsfromanestedcasecontrolstudyusingnationalhealthinsurancedata
AT minjeongkim protonpumpinhibitorsandlikelihoodofcolorectalcancerinthekoreanpopulationinsightsfromanestedcasecontrolstudyusingnationalhealthinsurancedata
AT nanyoungkim protonpumpinhibitorsandlikelihoodofcolorectalcancerinthekoreanpopulationinsightsfromanestedcasecontrolstudyusingnationalhealthinsurancedata
AT hyogeunchoi protonpumpinhibitorsandlikelihoodofcolorectalcancerinthekoreanpopulationinsightsfromanestedcasecontrolstudyusingnationalhealthinsurancedata
AT hosukkang protonpumpinhibitorsandlikelihoodofcolorectalcancerinthekoreanpopulationinsightsfromanestedcasecontrolstudyusingnationalhealthinsurancedata